Geron (GERN) | Financial Analysis & Statements
Geron Corporation Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
48.0M
Gross Profit
46.7M
97.28%
Operating Income
-8.5M
-17.72%
Net Income
-28.9M
-60.11%
EPS (Diluted)
$-0.05
Balance Sheet Metrics
Total Assets
570.5M
Total Liabilities
344.7M
Shareholders Equity
225.9M
Debt to Equity
1.53
Cash Flow Metrics
Operating Cash Flow
-45.1M
Free Cash Flow
-22.1M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Geron Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 183.9M | 77.0M | 237.0K | 596.0K | 1.4M |
| Cost of Goods Sold | 4.7M | 1.3M | - | - | - |
| Gross Profit | 179.1M | 75.7M | - | - | - |
| Gross Margin % | 97.4% | 98.4% | 0.0% | 0.0% | 0.0% |
| Operating Expenses | |||||
| Research & Development | 71.4M | 103.7M | 125.0M | 95.5M | 85.7M |
| Selling, General & Administrative | 159.3M | 145.7M | 69.1M | 43.6M | 29.7M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 230.7M | 249.5M | 194.2M | 139.1M | 115.4M |
| Operating Income | -51.6M | -173.7M | -193.9M | -138.6M | -114.0M |
| Operating Margin % | -28.0% | -225.6% | -81,832.9% | -23,246.6% | -8,183.7% |
| Non-Operating Items | |||||
| Interest Income | 18.1M | 19.6M | 18.2M | 2.5M | 527.0K |
| Interest Expense | 32.7M | 18.5M | 8.3M | 6.9M | 3.7M |
| Other Non-Operating Income | -17.4M | -1.9M | -23.0K | 1.0M | 1.1M |
| Pre-tax Income | -83.5M | -174.6M | -184.1M | -141.9M | -116.1M |
| Income Tax | - | - | - | - | - |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | -83.5M | -174.6M | -184.1M | -141.9M | -116.1M |
| Net Margin % | -45.4% | -226.7% | -77,690.7% | -23,808.9% | -8,335.4% |
| Key Metrics | |||||
| EBITDA | -32.6M | -153.1M | -174.8M | -134.2M | -111.6M |
| EPS (Basic) | $-0.13 | $-0.27 | $-0.32 | $-0.37 | $-0.35 |
| EPS (Diluted) | $-0.13 | $-0.27 | $-0.32 | $-0.37 | $-0.35 |
| Basic Shares Outstanding | 666662989 | 646033247 | 570645405 | 380784846 | 327631814 |
| Diluted Shares Outstanding | 666662989 | 646033247 | 570645405 | 380784846 | 327631814 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Geron Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 77.6M | 79.0M | 70.0M | 56.8M | 34.9M |
| Short-term Investments | 280.4M | 327.6M | 263.7M | 115.9M | 148.9M |
| Accounts Receivable | 37.0M | 35.9M | - | - | - |
| Inventory | 116.6M | 38.7M | - | - | - |
| Other Current Assets | 4.6M | 5.1M | 4.9M | 4.0M | 1.4M |
| Total Current Assets | 520.3M | 491.0M | 341.3M | 180.2M | 187.2M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 |
| Goodwill | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 5.9M | 4.1M | 4.7M | 5.4M | 4.8M |
| Total Non-Current Assets | 50.3M | 102.8M | 52.7M | 10.3M | 38.8M |
| Total Assets | 570.5M | 593.8M | 394.1M | 190.6M | 226.0M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 11.3M | 8.6M | 6.2M | 10.2M | 6.7M |
| Short-term Debt | 1.0M | 974.0K | 47.8M | 21.9M | 901.0K |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 17.4M | 20.4M | - | - | - |
| Total Current Liabilities | 111.5M | 88.3M | 108.1M | 76.7M | 45.5M |
| Non-Current Liabilities | |||||
| Long-term Debt | 121.0M | 120.7M | 38.1M | 33.9M | 54.1M |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 112.1M | 104.4M | - | - | - |
| Total Non-Current Liabilities | 233.1M | 225.2M | 38.1M | 33.9M | 54.1M |
| Total Liabilities | 344.7M | 313.5M | 146.1M | 110.6M | 99.6M |
| Equity | |||||
| Common Stock | 640.0K | 606.0K | 545.0K | 390.0K | 324.0K |
| Retained Earnings | -1.9B | -1.8B | -1.6B | -1.4B | -1.3B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 225.9M | 280.3M | 247.9M | 80.0M | 126.4M |
| Key Metrics | |||||
| Total Debt | 122.0M | 121.7M | 85.9M | 55.8M | 55.0M |
| Working Capital | 408.7M | 402.7M | 233.3M | 103.6M | 141.7M |
Balance Sheet Composition
Geron Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -83.5M | -174.6M | -184.1M | -141.9M | -116.1M |
| Depreciation & Amortization | 1.2M | 1.2M | 1.0M | 868.0K | 783.0K |
| Stock-Based Compensation | 26.7M | 31.3M | 19.4M | 8.3M | 8.2M |
| Working Capital Changes | -82.9M | -64.1M | -955.0K | 5.0M | -1.9M |
| Operating Cash Flow | -118.4M | -211.4M | -163.6M | -126.5M | -108.2M |
| Investing Activities | |||||
| Capital Expenditures | -49.0K | -680.0K | -830.0K | -431.0K | -207.0K |
| Acquisitions | - | - | - | - | 1.6M |
| Investment Purchases | -304.4M | -476.9M | -475.6M | -258.0M | -177.4M |
| Investment Sales | 411.7M | 371.6M | 296.1M | 320.5M | 249.6M |
| Investing Cash Flow | 107.2M | -106.0M | -180.3M | 62.1M | 73.5M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 0 | 121.1M | 29.7M | 0 | 24.9M |
| Debt Repayment | 0 | -86.6M | - | - | - |
| Financing Cash Flow | 0 | 300.3M | 243.0M | 69.9M | 45.3M |
| Free Cash Flow | -111.1M | -219.3M | -168.6M | -127.8M | -95.8M |
| Net Change in Cash | -11.2M | -17.1M | -100.9M | 5.5M | 10.7M |
Cash Flow Trend
Geron Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-11.54
Forward P/E
25.33
Price to Book
4.31
Price to Sales
5.30
PEG Ratio
-0.46
Profitability Ratios
Profit Margin
-45.41%
Operating Margin
-17.72%
Return on Equity
-32.99%
Return on Assets
-5.54%
Financial Health
Current Ratio
4.66
Debt to Equity
54.01
Beta
0.67
Per Share Data
EPS (TTM)
$-0.13
Book Value per Share
$0.35
Revenue per Share
$0.28
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| GERN | 961.4M | -11.54 | 4.31 | -32.99% | -45.41% | 54.01 |
| Vertex | 109.4B | 28.40 | 5.92 | 22.54% | 32.94% | 10.91 |
| Regeneron | 81.0B | 18.00 | 2.45 | 14.86% | 31.41% | 9.51 |
| Recursion | 1.9B | -2.44 | 1.64 | -59.54% | 4.45% | 6.89 |
| Capricor | 2.0B | -15.61 | 6.62 | -46.56% | 0.00% | 4.75 |
| Zymeworks | 2.0B | 3.79 | 7.32 | -26.72% | -76.56% | 6.80 |
Financial data is updated regularly. All figures are in the company's reporting currency.






